Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/17/2811132/30446/en/Aravive-Inc-to-Delist-from-The-Nasdaq-Stock-Market.html
https://www.fiercebiotech.com/biotech/aravive-weeks-liquidation-lays-70-its-staff-it-seeks-savior
https://www.fiercebiotech.com/biotech/araviv-ederci-phase-3-cancer-flop-blows-hole-plans-cast-strapped-biotech
https://www.globenewswire.com/news-release/2023/08/02/2717335/30446/en/Aravive-Announces-Top-Line-Results-from-Phase-3-AXLerate-OC-Study-of-Batiraxcept-in-Platinum-Resistant-Ovarian-Cancer.html
https://www.globenewswire.com/news-release/2023/07/28/2713027/30446/en/Aravive-to-Present-Updated-Clinical-Data-from-Batiraxcept-Trials-in-Renal-and-Pancreatic-Cancer-at-ESMO-Congress-2023.html
https://www.globenewswire.com/news-release/2023/07/14/2704921/30446/en/Aravive-to-Participate-in-William-Blair-s-Innovator-Series-Transitioning-Biotech-Breakthroughs-to-Commercial-Success-Being-Held-July-18-2023.html
https://www.globenewswire.com/news-release/2023/06/13/2687645/30446/en/Aravive-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c.html
https://www.globenewswire.com/news-release/2023/06/05/2682366/30446/en/Aravive-To-Participate-in-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2023/05/25/2676762/30446/en/Aravive-to-Present-Promising-Updated-Data-from-Phase-2-Trial-of-Batiraxcept-in-Combination-with-Cabozantinib-in-Clear-Cell-Renal-Cell-Carcinoma-at-ASCO-2023.html
https://www.globenewswire.com/news-release/2023/05/16/2669831/30446/en/Aravive-Announces-Phase-3-Trial-Design-for-Batiraxcept-in-Clear-Cell-Renal-Cell-Carcinoma.html